“We achieved organic ASV growth of 4.5% year-over-year, fueled by recent wins in wealth, dealmakers and partnerships.”（CEO）
“We anticipated stronger growth in the second half... we are pleased with our Q3 performance... we are reaffirming our FY '25 guidance.”（CEO）
“Our free cash flow grew to $229 million in the third quarter, up 5% over the same period last year.”（CFO）
“The third quarter showed strength in both financial and operating results.”（CFO）
“We are making targeted investments in our strategic priorities... We anticipate Q4 to be the highest quarter for expense this fiscal year.”（CFO）
Prepared Metrics
Metric
Value
Speaker/Context
有机ASV同比增长
4.5%
CEO, CFO
调整后运营利润率
36.8%
CEO, CFO
调整后稀释EPS
$4.27
CEO, CFO
GAAP收入
$586M（同比+5.9%）
CFO
有机收入
$577M（同比+4.4%）
CFO
自由现金流
$229M（同比+5%）
CFO
美洲有机ASV增长
5%
CEO
EMEA有机ASV增长
2%
CEO
亚太有机ASV增长
7%
CEO
ASV留存率
>95%
CEO
客户留存率
91%
CEO
Q&A Batch (1-5 of 17)
Q1 — Shlomo Rosenbaum
Topic: Macro environment and ASP growth drivers
Key points:
ASP growth turned up after over a year of sequential declines.
April saw a few weeks of clients waiting due to dynamic markets.
Momentum attributed to product execution, especially Data Solutions, buy-side offerings (Q4 boost), and GenAI tools (Pitch Creator, conversational API).
Mgmt stance: Bullish — attributes improvement to product resonance and execution, not macro tailwinds; pipeline supports rest of year.
Q2 — Alex Kramm
Topic: (Incomplete exchange — no content provided)
Key points: None.
Mgmt stance: Not applicable.
Q3 — Frederick Snow
Topic: Q4 growth drivers and pipeline confidence
Key points:
Significantly ahead of same time last 2 years; Americas and EMEA driving growth.
Core Workstation flat; strength from enterprise solutions (portfolio life cycle for buy side, feeds business).
Top 15 deals for Q4: ~10 (2/3) from institutional asset management.
Booked ASV/commitments well ahead of last year; improved retention; cancellations for next 90 days significantly improved.
Pipeline diverse across deal sizes, firm types, solutions; not dependent on any large deal.
Mgmt stance: Bullish — high confidence in reaching guided range; fast-developing deals can offset falloffs.
Q4 — Faiza Alwy
Topic: Fiscal 2026 outlook and acceleration beyond Q4
Key points:
Company does not discuss next fiscal year until September call.
Current trends expected to continue, but no specific guidance provided.
Mgmt stance: Neutral — defers forward-looking commentary to next earnings call.
Q5 — Ashish Sabadra
Topic: Asset owner headwinds and growth inflection
Key points:
Asset owner business faced headwinds this quarter due to clients streamlining vendor relationships.
Q4 pipeline for asset owners expected to outperform Q4 of last year.
Investments in LiquidityBook (to close MSA compliance gap) and total portfolio solutions are underway.
No similar quarter of headwinds expected in the future.
Mgmt stance: Cautiously optimistic — competitive area but expects improvement; Q4 pipeline shows tailwind.
Q&A Batch (6-10 of 17)
Q6 — Kwun Sum Lau
Topic: Fiscal Q4 margin trajectory vs. full-year guidance
Key points:
Adjusted operating margin for first 3 quarters is ~37.2%; Q4 would need to be ~34.6% to hit full-year midpoint.
Full-year adjusted margin guidance range is 36%–37%.
Pace of investments (data expansion, client workflow embedding, GenAI roadmap) has picked up over the year.
Mgmt stance: Neutral — comfortable delivering within the 36%–37% range; Q4 spend includes expertise for GenAI, acquisition integration (both slightly dilutive), and rising technology costs.
Q7 — Andrew Nicholas
Topic: Internal efficiency gains from GenAI and potential cost offsets
Key points:
Internal cost events coverage more than doubled from 7,000 to 15,000.
Engineering output improved 10% via coding assistance; AI-generated fund descriptions completed in 1/3 of the time.
Excluding acquisitions, head count is essentially flat to down; over 50 internal efficiency opportunities identified.
Mgmt stance: Bullish — applying GenAI internally (developer tools, client-facing admin tasks, data collection automation) expected to drive productivity and flat expense growth going forward.
Q8 — Surinder Thind
Topic: Operating leverage and peak investment timing over next 1–3 years
Key points:
Margin expected to land comfortably within the 36%–37% guidance range.
Recent acquisitions are slightly dilutive; investments are self-funded through lower hiring and efficiency gains.
Efficiency trends seen in fiscal 2025 are expected to continue into the next couple of years.
Mgmt stance: Neutral — no new long-term outlook provided beyond prior Investor Day; near-term margin within range, with ongoing self-funding of investments.
Q9 — Craig Huber
Topic: Cost growth breakdown and sales force investment
Biggest cost driver: bonus accrual (compensation) due to different performance level vs. prior year.
Tech expenses up 21% (internal-use software amortization and cloud spend); other expenses (facilities) down 20 bps as % of revenue; third-party costs managed lower.
Mgmt stance: Neutral — sales force head count relatively flat; investment focused on product specialty side, not broad sales force expansion.
Q10 — Toni Kaplan
Topic: GenAI deal composition (Pitch Creator) and competitive landscape
Key points:
10 signed deals and 45 opportunities; most signed deals are with existing clients adopting Pitch Creator as part of overall solutions.
Pitch Creator has been in market less than 4–5 months; pipeline includes new business wins from Pitch Creator sentiment.
No mention of competitive products in the marketplace.
Mgmt stance: Bullish — Pitch Creator expected to contribute to cross-selling, upselling, and winning new business.